[Treatment of intestinal amebiasis with a compound of iodochloroxyquinoline +5,6-quinono-4,7-phenantrothroline].
D000563:Amebicides / Q000627:therapeutic use*; D007464:Clioquinol / Q000627:therapeutic use*; D004404:Dysentery, Amebic / Q000188:drug therapy*; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D010115:Oxyphenonium / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D010618:Phenanthrolines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D000563:Amebicides; D008333:Mandelic Acids; D010276:Parasympatholytics; D010618:Phenanthrolines; D000644:Quaternary Ammonium Compounds; D007464:Clioquinol; D010115:Oxyphenonium
Tratamento da amebiase intestinal com a associação iodocloroxiquinoleína + 5,6-quinono-4,7-fenantrolina.